WallStreetZenWallStreetZen

NASDAQ: MREO
Mereo Biopharma Group PLC Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Mereo Biopharma Group earnings were -$35.7M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest MREO earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$6.7M, down 8.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MREO reported annual earnings of -$41.9M, with -3.2% growth.

MREO earnings history

Current Revenue
$500.0k
Current Earnings
-$35.7M
Current Profit Margin
-7,142%

MREO Return on Equity

Current Company
-81.3%
Current Industry
-141.9%
Current Market
13.5%
MREO's Return on Equity (-81.3%)... subscribe to Premium to read more.
High Return on Equity Performance

MREO Return on Assets

Current Company
-70.4%
Current Industry
-13.7%
MREO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MREO announces earnings.

MREO Return on Capital Employed

Current Company
-108.53%
Current Industry
-9.5%

MREO vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MREO-$36.19M-$35.71MN/A-$0.25
ACTU-$21.52M-$21.54MN/A-$0.97
TIL-$40.76M-$47.38MN/A-$7.04
VERU-$13.84M-$13.95MN/A-$0.78
DWTX-$28.09M-$28.32MN/A$0.55
View Top Biotech Stocks

Mereo Biopharma Group Earnings Reports & History FAQ

What were Mereo Biopharma Group's earnings last quarter?

On MREO's earnings call on Invalid Date, Mereo Biopharma Group (NASDAQ: MREO) reported Q1 2026 earnings per share (EPS) of -$0.05, up 50% year over year. Total MREO earnings for the quarter were -$6.72 million. In the same quarter last year, Mereo Biopharma Group's earnings per share (EPS) was -$0.10.

If you're new to stock investing, here's how to buy Mereo Biopharma Group stock.

Is Mereo Biopharma Group profitable or losing money?

As of the last Mereo Biopharma Group earnings report, Mereo Biopharma Group is currently losing money. Mereo Biopharma Group's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$35.71 million, a 24.33% decrease year over year.

What was MREO's earnings growth in the past year?

As of Mereo Biopharma Group's earnings date in Invalid Date, Mereo Biopharma Group's earnings has grown year over year. MREO earnings in the past year totalled -$35.71 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.